NCT00372476View on ClinicalTrials.gov

Efficacy and Safety of Imatinib and Vinorelbine in Patients With Advanced Breast Cancer

PHASE4CompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

June 30, 2006

Primary Completion Date

July 31, 2012

Study Completion Date

July 31, 2012

Conditions
Breast Cancer
Interventions
DRUG

Imatinib and Vinorelbine

Trial Locations (1)

24105

Novartis Investigative Site, Kiel

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY